Polygenic Embryo Screening: High Approval Despite Substantial Concerns from the U.S. Public

Rémy A. Furrer, Dorit Barlevy, Stacey Pereira, Shai Carmi, Todd Lencz, Gabriel Lázaro-Muñoz
doi: https://doi.org/10.1101/2023.10.13.23297022

Article Information

doi 
https://doi.org/10.1101/2023.10.13.23297022
History 
  • October 14, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Rémy A. Furrer1,*,
  2. Dorit Barlevy2,
  3. Stacey Pereira2,
  4. Shai Carmi3,
  5. Todd Lencz4,5,6 and
  6. Gabriel Lázaro-Muñoz1,7
  1. 1Center for Bioethics, Harvard Medical School
  2. 2Center for Medical Ethics and Health Policy, Baylor College of Medicine
  3. 3Braun School of Public Health and Community Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112102, Israel
  4. 4Institute of Behavioral Science, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY
  5. 5Departments of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
  6. 6Department of Psychiatry, Division of Research, The Zucker Hillside Hospital Division of Northwell Health, Glen Oaks, NY
  7. 7Department of Psychiatry, Massachusetts General Hospital
  1. ↵* Corresponding author; email: remy_furrer{at}hms.harvard.edu
Back to top
Posted October 14, 2023.
Download PDF
Data/Code
Email
Polygenic Embryo Screening: High Approval Despite Substantial Concerns from the U.S. Public
Rémy A. Furrer, Dorit Barlevy, Stacey Pereira, Shai Carmi, Todd Lencz, Gabriel Lázaro-Muñoz
medRxiv 2023.10.13.23297022; doi: https://doi.org/10.1101/2023.10.13.23297022
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area